Publications by authors named "Christoph Hallmann"

Claim this Profile
T
Tiotropium and olodaterol in the prevention of chronic obstructive pulmonary disease exacerbations (DYNAGITO): a double-blind, randomised, parallel-group, active-controlled trial.
Peter M A Calverley, Antonio R Anzueto, Kerstine Carter, Lars Grönke, Christoph Hallmann

Lancet Respir Med· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eosinophilia, Frequent Exacerbations, and Steroid Response in Chronic Obstructive Pulmonary Disease.
Peter M A Calverley, Kay Tetzlaff, Claus Vogelmeier, Leonardo M Fabbri, Helgo Magnussen, Christoph Hallmann

Am J Respir Crit Care Med· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis.
Harold R Collard, Luca Richeldi, Dong Soon Kim, Hiroyuki Taniguchi, Inga Tschoepe, Christoph Hallmann

Eur Respir J· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume.
Martin Kolb, Luca Richeldi, Jürgen Behr, Toby M Maher, Wenbo Tang, Christoph Hallmann

Thorax· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of tiotropium on exacerbations versus glycopyrronium and QVA149.
Norbert Metzdorf, Christoph Hallmann, Bernd Disse

Expert Rev Respir Med· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Essential criteria for pharmacokinetic studies supporting bioequivalence of inhaled tiotropium bromide products.
Ashish Sharma, Benjamin Weber, Martina Wein, Christoph Hallmann, Bernd Meibohm

Clin Pharmacol Drug Dev· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New guideline for idiopathic pulmonary fibrosis.
Susanne Stowasser, Christoph Hallmann

Lancet· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tiotropium + olodaterol shows clinically meaningful improvements in quality of life.
Dave Singh, Gary T Ferguson, Josef Bolitschek, Lars Grönke, Christoph Hallmann

Respir Med· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis.
David Mg Halpin, Ronald Dahl, Christoph Hallmann, Achim Mueller, Donald Tashkin

Int J Chron Obstruct Pulmon Dis· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thorax editorial by Jenkins and Beasley related to tiotropium respimat.
Norbert Metzdorf, Christoph Hallmann, Bernd Disse

Thorax· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis